Medically reviewed by Steffini Stalos, DOFact checked by Nick BlackmerMedically reviewed by Steffini Stalos, DOFact checked ...
Cologuard was about three times more likely to give a false positive result — meaning no cancer was found on the follow-up colonoscopy. Lives saved. The bottom line for any cancer screening test ...
There's a new blood test to screen for colorectal cancer, but a new study found it's not as effective as a colonoscopy or ...
The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults aged 45 years at average risk for colorectal cancer. The Food and Drug Administration (FDA) has approved the ...
Exact Sciences shares plunged Wednesday after the maker of Cologuard reported widening losses and cut its outlook.
Shield is similar to Cologuard in that it will be recommended if you are at average risk for colorectal cancer, meaning you are not experiencing any symptoms related to colorectal cancer and do ...
Cologuard Plusâ„¢ test raises the performance bar with sensitivities of 95% for colorectal cancer and 43% for advanced precancerous lesions at 94% specificity Cologuard Plus test will minimize ...
Exact Sciences EXAS recently received FDA approval for its next-generation multitarget stool DNA test, Cologuard Plus. This marks a significant advancement for the company in the field of ...
Puneet Souda’s rating is based on the expectation of broader adoption and higher volumes for Exact Sciences’s Cologuard Plus (CG+), which is anticipated to have higher specificity compared to ...
Exact Sciences shares plunged Wednesday after the company reported widening losses. The maker of the Cologuard colon cancer screening test lowered its full-year outlook. CEO Kevin Conroy said the ...